Cellectis (CLLS) Tops Q1 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.96 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Northern Technologies (NTIC) Misses Q3 EPS by 12c
• Scienture to ship naloxone nasal spray to wholesalers in July
• Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'